Clinical Trial Update: Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

A dose-defining study of tirapazamine combined with embolization in liver cancer (hepatocellular carcinoma) is in Phase 1/Phase 2 and currently recruiting, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancers
• Hepatocellular Carcinoma
• Neuroendocrine Tumors

Drugs mentioned

• Tirapazamine (tirapazamine)

Snippet

Sponsor: Teclison Ltd. | Conditions: Hepatocellular Carcinoma, Gastrointestinal Cancer Metastatic | Phase 1, Phase 2 | Status: RECRUITING